Skip to content
10-K/A

Annual Report

BIOSYNERGY INC

0000715812-19-000020

← back to feed
Filed
Aug 2, 2019 12:00 AM ET
Period of report
Amendment. Amends a previously filed report.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2019 · Apr 30, 2019 14.94M sh
Capex FY 2019 · Apr 30, 2019 $11.02K
Operating Cash Flow FY 2019 · Apr 30, 2019 $50.72K
Operating Cash Flow FY 2019 · Apr 30, 2018 $99.85K
Cash And Equivalents FY 2019 · Apr 30, 2019 $1.18M
Cash And Equivalents FY 2019 · Apr 30, 2018 $1.14M
Cash And Equivalents FY 2019 · Apr 30, 2017 $1.04M
Stockholders Equity FY 2019 · Apr 30, 2019 $1.69M
Stockholders Equity FY 2019 · Apr 30, 2018 $1.62M
Stockholders Equity FY 2019 · Apr 30, 2017 $1.59M
Current Liabilities FY 2019 · Apr 30, 2019 $156.29K
Current Liabilities FY 2019 · Apr 30, 2018 $70.63K
Current Assets FY 2019 · Apr 30, 2019 $1.65M
Current Assets FY 2019 · Apr 30, 2018 $1.57M
Total Assets FY 2019 · Apr 30, 2019 $1.87M
Total Assets FY 2019 · Apr 30, 2018 $1.71M
Sga Expense FY 2019 · Apr 30, 2019 $418.96K
Sga Expense FY 2019 · Apr 30, 2018 $433.13K
Rd Expense FY 2019 · Apr 30, 2019 $160.35K
Rd Expense FY 2019 · Apr 30, 2018 $169.89K
Net Income FY 2019 · Apr 30, 2019 $73.49K
Net Income FY 2019 · Apr 30, 2018 $33.11K
Operating Income FY 2019 · Apr 30, 2019 $100.33K
Operating Income FY 2019 · Apr 30, 2018 $32.4K
Gross Profit FY 2019 · Apr 30, 2019 $868.88K
Gross Profit FY 2019 · Apr 30, 2018 $822.24K
Revenue FY 2019 · Apr 30, 2019 $1.29M
Revenue FY 2019 · Apr 30, 2018 $1.21M